title: Doxorubicin concentrations in plasma and myocardium and their respective roles in cardiotoxicity.
abstract: Three hours after the intravenous infusion of doxorubicin (3 mg/kg over 15 min) to anesthetized dogs, the drug concentration was found much higher in the myocardium than in the plasma (about 4,000 ng/g, i.e., 50 times higher). After the intravenous infusion of doxorubicin (1.5 mg/kg over 15 min) to conscious dogs, the drug concentration appeared to decline very slowly in the myocardium, since it was close to 200 ng/g at the 7th day, whereas the plasma concentration had fallen to zero, and the drug was still detected in the cardiac tissue 21 days after the administration. As myocardial concentrations of doxorubicin persist long after plasma clearance is complete, the hazards of repeated administration, based on plasma kinetic patterns, must be emphasized.
authors.affiliation: Medical Pharmacology Department, Claude Bernard University, Lyon, France.
authors.forename: Q
authors.initials: Q
authors.lastname: Timour
authors.forename: P
authors.initials: P
authors.lastname: Nony
authors.forename: J
authors.initials: J
authors.lastname: Lang
authors.forename: M
authors.initials: M
authors.lastname: Lakhal
authors.forename: V
authors.initials: V
authors.lastname: Trillet
authors.forename: G
authors.initials: G
authors.lastname: Faucon
mesh_terms: D000818:Animals; D004285:Dogs; D004317:Doxorubicin / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity*; D006321:Heart / Q000187:drug effects*; D007262:Infusions, Intravenous; D009206:Myocardium / Q000378:metabolism*
chemical_list: D004317:Doxorubicin